Around 3000 vehicles will be impacted by the pause in production at Nissan's plant in Kyushu.
- shares

Japanese automaker Nissan has been forced to temporarily cease production over two days at its plant in Kyushu as a result of parts shortages caused by the widespread coronavirus epidemic.

UPDATE (11/02/20): We've updated this story with a statement from Nissan below.

"Due to supply shortages of parts from China, Nissan Kyushu in Japan will carry out temporary production adjustments on February 14 and 17," a Nissan spokesperson said.

The Kyushu factory relies heavily on Chinese-supplied auto parts to make vehicles like the Serena minivan and the Rogue Sport crossover (Nissan's top-selling car in the United States) and produced 434,000 vehicles in the 2018 fiscal year.

The break in operations is expected to reduce production by 3000 vehicles, according to Japanese newspaper Nikkei.

Nikkei reports that the Chinese automotive market accounts for 30 per cent of all of Japan's auto parts imports. As of 2018, China accounted for 8.5 per cent of all global auto parts exports.

The Japan production halt comes after Nissan was forced to close several of its plants in China, some of which are expected to reopen in the coming week after a longer-than-planned hiatus.

"In full compliance with government directives and in view of the situation of the epidemic and our suppliers, we are preparing to restart production in China at the earliest from February 17 at Huadu Plant and Dalian Plant," a Nissan spokesperson said.

"Restart dates for other plants will differ by plant and we will update as necessary."

Nissan joins a growing list of manufacturers whose factories outside of China have been hit with shortages and closures.

Hyundai and Kia have both temporarily paused production at their South Korean plants, while Fiat Chrysler has warned of possible European plant closures and Japan's Isuzu is reportedly considering alternate options in anticipation of parts shortages.

Originating in the city of Wuhan, the coronavirus has claimed over 800 lives and the number of confirmed infections exceeds 37,000 as of time of publishing, with the majority of them in China's Hubei Province.